AMGN
$327.37
Revenue | $9557Mn |
Net Profits | $3216Mn |
Net Profit Margins | 33.65% |
Amgen Inc.’s revenue jumped 12.4% since last year same period to $9557Mn in the Q3 2025. On a quarterly growth basis, Amgen Inc. has generated 4.25% jump in its revenue since last 3-months.
Amgen Inc.’s net profit jumped 13.64% since last year same period to $3216Mn in the Q3 2025. On a quarterly growth basis, Amgen Inc. has generated 124.58% jump in its net profits since last 3-months.
Amgen Inc.’s net profit margin jumped 1.11% since last year same period to 33.65% in the Q3 2025. On a quarterly growth basis, Amgen Inc. has generated 115.42% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 4.72 |
EPS Estimate Current Year | 4.72 |
Amgen Inc.’s earning per share (EPS) estimates for the current quarter stand at 4.72 - a -5.98% fall from last quarter’s estimates.
Amgen Inc.’s earning per share (EPS) estimates for the current year stand at 4.72.
Earning Per Share (EPS) | 5.64 |
Dividend Per Share (DPS) | 2.38 |
Amgen Inc.’s earning per share (EPS) jumped 1.08% since last year same period to 5.64 in the Q3 2025. This indicates that the Amgen Inc. has generated 1.08% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Amgen Inc. declared 2.38 dividend per share during the earnings announcement for Q3 2025.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-02 | 4.26 | 4.9 | 15.02% |
2025-08-06 | 5.28 | 6.02 | 14.02% |
2025-11-05 | 5.02 | 5.64 | 12.35% |